{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:21:56Z","timestamp":1767964916969,"version":"3.49.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1ZIATR000058-03"],"award-info":[{"award-number":["1ZIATR000058-03"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Over the last few decades, chemists have become skilled at designing compounds that avoid cytochrome P\u00a0(CYP) 450 mediated metabolism. Typical screening assays are performed in liver microsomal fractions and it is possible to overlook the contribution of cytosolic enzymes until much later in the drug discovery process. Few data exist on cytosolic enzyme-mediated metabolism and no reliable tools are available to chemists to help design away from such liabilities. In this study, we screened 1450 compounds for liver cytosol-mediated metabolic stability\u00a0and extracted transformation rules that might help medicinal chemists in optimizing compounds with these liabilities. In vitro half-life data were collected by performing<jats:italic>in<\/jats:italic>-<jats:italic>house<\/jats:italic>experiments in mouse (CD-1 male) and human (mixed gender)\u00a0cytosol fractions. Matched molecular pairs analysis was performed in conjunction with qualitative-structure activity relationship modeling to identify chemical structure transformations affecting cytosolic stability. The transformation rules were prospectively validated on the test set. In addition, selected rules were validated on a diverse chemical library and the resulting pairs were experimentally tested to confirm whether the identified transformations could be generalized. The validation results, comprising nearly 250 library compounds and corresponding half-life data, are made publicly available. The datasets were also used to generate in silico classification models, based on different molecular descriptors and machine learning methods, to predict cytosol-mediated liabilities. To the best of our knowledge, this is the first systematic in silico effort to address cytosolic enzyme-mediated liabilities.<\/jats:p>","DOI":"10.1186\/s13321-020-00426-7","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T13:02:58Z","timestamp":1586264578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Predicting liver cytosol stability of small molecules"],"prefix":"10.1186","volume":"12","author":[{"given":"Pranav","family":"Shah","sequence":"first","affiliation":[]},{"given":"Vishal B.","family":"Siramshetty","sequence":"additional","affiliation":[]},{"given":"Alexey V.","family":"Zakharov","sequence":"additional","affiliation":[]},{"given":"Noel T.","family":"Southall","sequence":"additional","affiliation":[]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[]},{"given":"Dac-Trung","family":"Nguyen","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"issue":"5","key":"426_CR1","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2133\/dmpk.DMPK-12-RV-042","volume":"27","author":"T Fukami","year":"2012","unstructured":"Fukami T, Yokoi T (2012) The emerging role of human esterases. Drug Metab Pharmacokinet 27(5):466\u2013477","journal-title":"Drug Metab Pharmacokinet"},{"issue":"8","key":"426_CR2","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1124\/dmd.110.032375","volume":"38","author":"S Diamond","year":"2010","unstructured":"Diamond S, Boer J, Maduskuie TP Jr, Falahatpisheh N, Li Y, Yeleswaram S (2010) Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications. Drug Metab Dispos 38(8):1277\u20131285","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"426_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.dmpk.2014.10.009","volume":"30","author":"S Sanoh","year":"2015","unstructured":"Sanoh S, Tayama Y, Sugihara K, Kitamura S, Ohta S (2015) Significance of aldehyde oxidase during drug development: effects on drug metabolism, pharmacokinetics, toxicity, and efficacy. Drug Metab Pharmacokinet 30(1):52\u201363","journal-title":"Drug Metab Pharmacokinet"},{"issue":"5","key":"426_CR4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/00498254.2010.549970","volume":"41","author":"T Akabane","year":"2011","unstructured":"Akabane T, Tanaka K, Irie M, Terashita S, Teramura T (2011) Case report of extensive metabolism by aldehyde oxidase in humans: pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans. Xenobiotica 41(5):372\u2013384","journal-title":"Xenobiotica"},{"issue":"23","key":"426_CR5","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S1359-6446(04)03280-5","volume":"9","author":"AE Nassar","year":"2004","unstructured":"Nassar AE, Kamel AM, Clarimont C (2004) Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability. Drug Discov Today 9(23):1020\u20131028","journal-title":"Drug Discov Today"},{"key":"426_CR6","unstructured":"Kerns EH, Di L (2008) Drug-like properties: concepts, structure design and methods. pp 1\u2013528"},{"issue":"8","key":"426_CR7","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1021\/acsomega.7b00658","volume":"2","author":"M Montefiori","year":"2017","unstructured":"Montefiori M, J\u00f8rgensen FS, Olsen L (2017) Aldehyde oxidase: reaction mechanism and prediction of site of metabolism. Acs Omega 2(8):4237\u20134244","journal-title":"Acs Omega"},{"issue":"4","key":"426_CR8","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1021\/jm4017976","volume":"57","author":"F O\u2019Hara","year":"2014","unstructured":"O\u2019Hara F, Burns AC, Collins MR, Dalvie D, Ornelas MA, Vaz ADN, Fujiwara Y, Baran PS (2014) A simple litmus test for aldehyde oxidase metabolism of heteroarenes. J Med Chem 57(4):1616\u20131620","journal-title":"J Med Chem"},{"issue":"5","key":"426_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1124\/dmd.118.085787","volume":"47","author":"A Abbasi","year":"2019","unstructured":"Abbasi A, Paragas EM, Joswig-Jones CA, Rodgers JT, Jones JP (2019) Time course of aldehyde oxidase and why it is nonlinear. Drug Metab Dispos 47(5):473","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"426_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/713803569","volume":"48","author":"S Kitamura","year":"1999","unstructured":"Kitamura S, Sugihara K, Nakatani K, Ohta S, Oh-Hara T, Ninomiya S-I, Green CE, Tyson CA (1999) Variation of hepatic methotrexate 7-hydroxylase activity in animals and humans. IUBMB Life 48(6):607\u2013611","journal-title":"IUBMB Life"},{"key":"426_CR11","first-page":"271","volume":"22","author":"PW Kenny","year":"2005","unstructured":"Kenny PW, Sadowski J (2005) Structure modification in chemical databases. Methods Princ Med Chem 22:271\u2013285","journal-title":"Methods Princ Med Chem"},{"issue":"15","key":"426_CR12","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.drudis.2013.03.003","volume":"18","author":"AG Dossetter","year":"2013","unstructured":"Dossetter AG, Griffen EJ, Leach AG (2013) Matched molecular pair analysis in drug discovery. Drug Discov Today 18(15):724\u2013731","journal-title":"Drug Discov Today"},{"issue":"22","key":"426_CR13","doi-asserted-by":"publisher","first-page":"7739","DOI":"10.1021\/jm200452d","volume":"54","author":"E Griffen","year":"2011","unstructured":"Griffen E, Leach AG, Robb GR, Warner DJ (2011) Matched molecular pairs as a medicinal chemistry tool. J Med Chem 54(22):7739\u20137750","journal-title":"J Med Chem"},{"issue":"23","key":"426_CR14","doi-asserted-by":"publisher","first-page":"6672","DOI":"10.1021\/jm0605233","volume":"49","author":"AG Leach","year":"2006","unstructured":"Leach AG, Jones HD, Cosgrove DA, Kenny PW, Ruston L, MacFaul P, Wood JM, Colclough N, Law B (2006) Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure. J Med Chem 49(23):6672\u20136682","journal-title":"J Med Chem"},{"issue":"10","key":"426_CR15","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1124\/dmd.116.072017","volume":"44","author":"P Shah","year":"2016","unstructured":"Shah P, Kerns E, Nguyen DT, Obach RS, Wang AQ, Zakharov A, McKew J, Simeonov A, Hop CE, Xu X (2016) An automated high-throughput metabolic stability assay using an integrated high-resolution accurate mass method and automated data analysis software. Drug Metab Dispos 44(10):1653\u20131661","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"426_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1021\/ci900450m","volume":"50","author":"J Hussain","year":"2010","unstructured":"Hussain J, Rea C (2010) Computationally efficient algorithm to identify matched molecular pairs (MMPs) in large data sets. J Chem Inf Model 50(3):339\u2013348","journal-title":"J Chem Inf Model"},{"key":"426_CR17","doi-asserted-by":"crossref","unstructured":"Berthold MR, Cebron N, Dill F, Gabriel TR, Kotter T, Meinl T, Ohl P, Sieb C, Thiel K, Wiswedel B (2008) KNIME: the Konstanz Information Miner. Stud Class Data Anal. pp 319\u2013326","DOI":"10.1007\/978-3-540-78246-9_38"},{"key":"426_CR18","doi-asserted-by":"publisher","DOI":"10.2174\/0929867325666180904113616","author":"S Roughley","year":"2018","unstructured":"Roughley S (2018) Five years of the KNIME vernalis cheminformatics community contribution. Curr Med Chem. https:\/\/doi.org\/10.2174\/0929867325666180904113616","journal-title":"Curr Med Chem"},{"key":"426_CR19","unstructured":"RDKit: Open-source cheminformatics. http:\/\/www.rdkit.org"},{"issue":"1","key":"426_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L (2001) Random forests. Mach Learn 45(1):5\u201332","journal-title":"Mach Learn"},{"issue":"3","key":"426_CR21","first-page":"273","volume":"20","author":"C Cortes","year":"1995","unstructured":"Cortes C, Vapnik V (1995) Support-vector networks. Mach Learn 20(3):273\u2013297","journal-title":"Mach Learn"},{"issue":"1","key":"426_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1517\/17460441.2014.866943","volume":"9","author":"K Heikamp","year":"2014","unstructured":"Heikamp K, Bajorath J (2014) Support vector machines for drug discovery. Expert Opin Drug Discov 9(1):93\u2013104","journal-title":"Expert Opin Drug Discov"},{"key":"426_CR23","unstructured":"Bouckaert RR (2004) Bayesian network classifiers in weka"},{"issue":"6","key":"426_CR24","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1021\/ci200409x","volume":"52","author":"A Varnek","year":"2012","unstructured":"Varnek A, Baskin I (2012) Machine learning methods for property prediction in chemoinformatics: Quo Vadis? J Chem Inf Model 52(6):1413\u20131437","journal-title":"J Chem Inf Model"},{"issue":"15","key":"426_CR25","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.4155\/fmc.12.152","volume":"4","author":"AV Zakharov","year":"2012","unstructured":"Zakharov AV, Peach ML, Sitzmann M, Filippov IV, McCartney HJ, Smith LH, Pugliese A, Nicklaus MC (2012) Computational tools and resources for metabolism-related property predictions. 2. Application to prediction of half-life time in human liver microsomes. Future Med Chem 4(15):1933\u20131944","journal-title":"Future Med Chem"},{"key":"426_CR26","unstructured":"Chemical Computing Group I (2008) MOE (molecular operating environment). Montreal, Canada"},{"issue":"2\u20133","key":"426_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/minf.201000151","volume":"30","author":"A Lagunin","year":"2011","unstructured":"Lagunin A, Zakharov A, Filimonov D, Poroikov V (2011) QSAR modelling of rat acute toxicity on the basis of PASS prediction. Mol Inform 30(2\u20133):241\u2013250","journal-title":"Mol Inform"},{"issue":"7\u20138","key":"426_CR28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/10629360903438370","volume":"20","author":"DA Filimonov","year":"2009","unstructured":"Filimonov DA, Zakharov AV, Lagunin AA, Poroikov VV (2009) QNA-based \u2018Star Track\u2019 QSAR approach. SAR QSAR Environ Res 20(7\u20138):679\u2013709","journal-title":"SAR QSAR Environ Res"},{"issue":"8","key":"426_CR29","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1021\/acs.jcim.9b00237","volume":"59","author":"K Yang","year":"2019","unstructured":"Yang K, Swanson K, Jin W, Coley C, Eiden P, Gao H, Guzman-Perez A, Hopper T, Kelley B, Mathea M et al (2019) Analyzing learned molecular representations for property prediction. J Chem Inf Model 59(8):3370\u20133388","journal-title":"J Chem Inf Model"},{"issue":"2","key":"426_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1039\/C7SC02664A","volume":"9","author":"Z Wu","year":"2018","unstructured":"Wu Z, Ramsundar B, Feinberg Evan N, Gomes J, Geniesse C, Pappu AS, Leswing K, Pande V (2018) MoleculeNet: a benchmark for molecular machine learning. Chem Sci 9(2):513\u2013530","journal-title":"Chem Sci"},{"issue":"3","key":"426_CR31","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1021\/ci400737s","volume":"54","author":"AV Zakharov","year":"2014","unstructured":"Zakharov AV, Peach ML, Sitzmann M, Nicklaus MC (2014) QSAR modeling of imbalanced high-throughput screening data in PubChem. J Chem Inf Model 54(3):705\u2013712","journal-title":"J Chem Inf Model"},{"issue":"1","key":"426_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/tpj.2010.8","volume":"11","author":"X Zhang","year":"2011","unstructured":"Zhang X, Liu HH, Weller P, Zheng M, Tao W, Wang J, Liao G, Monshouwer M, Peltz G (2011) In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor. Pharmacogenomics J 11(1):15\u201324","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"426_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3109\/00498258509045354","volume":"15","author":"B Kaye","year":"1985","unstructured":"Kaye B, Rance DJ, Waring L (1985) Oxidative metabolism of carbazeran in vitro by liver cytosol of baboon and man. Xenobiotica 15(3):237\u2013242","journal-title":"Xenobiotica"},{"issue":"12","key":"426_CR34","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1016\/j.bmc.2011.05.003","volume":"19","author":"CE Keefer","year":"2011","unstructured":"Keefer CE, Chang G, Kauffman GW (2011) Extraction of tacit knowledge from large ADME data sets via pairwise analysis. Bioorg Med Chem 19(12):3739\u20133749","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"426_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2165\/00003088-199835050-00003","volume":"35","author":"JH Lin","year":"1998","unstructured":"Lin JH, Lu AY (1998) Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet 35(5):361\u2013390","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"426_CR36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1517\/17425255.2014.876006","volume":"10","author":"L Di","year":"2014","unstructured":"Di L (2014) The role of drug metabolizing enzymes in clearance. Expert Opin Drug Metab Toxicol 10(3):379\u2013393","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"24","key":"426_CR37","doi-asserted-by":"publisher","first-page":"8441","DOI":"10.1021\/jm100888d","volume":"53","author":"DC Pryde","year":"2010","unstructured":"Pryde DC, Dalvie D, Hu Q, Jones P, Obach RS, Tran TD (2010) Aldehyde oxidase: an enzyme of emerging importance in drug discovery. J Med Chem 53(24):8441\u20138460","journal-title":"J Med Chem"},{"issue":"6","key":"426_CR38","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1208\/s12248-016-9962-6","volume":"18","author":"UA Argikar","year":"2016","unstructured":"Argikar UA, Potter PM, Hutzler JM, Marathe PH (2016) Challenges and opportunities with non-CYP enzymes aldehyde oxidase, carboxylesterase, and UDP-glucuronosyltransferase: focus on reaction phenotyping and prediction of human clearance. AAPS J 18(6):1391\u20131405","journal-title":"AAPS J"},{"key":"426_CR39","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1039\/9781849731102-00328","volume":"1","author":"D Dalvie","year":"2010","unstructured":"Dalvie D, Kang P, Loi CM, Goulet L, Nair S (2010) Influence of heteroaromatic rings on ADME properties of drugs. Rsc Drug Discov 1:328\u2013369","journal-title":"Rsc Drug Discov"},{"issue":"6","key":"426_CR40","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1517\/17460441.2013.788497","volume":"8","author":"E Garattini","year":"2013","unstructured":"Garattini E, Terao M (2013) Aldehyde oxidase and its importance in novel drug discovery: present and future challenges. Expert Opin Drug Discov 8(6):641\u2013654","journal-title":"Expert Opin Drug Discov"},{"issue":"2","key":"426_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2133\/dmpk.DMPK-11-RG-097","volume":"27","author":"T Akabane","year":"2012","unstructured":"Akabane T, Gerst N, Naritomi Y, Masters JN, Tamura K (2012) A practical and direct comparison of intrinsic metabolic clearance of several non-CYP enzyme substrates in freshly isolated and cryopreserved hepatocytes. Drug Metab Pharmacokinet 27(2):181\u2013191","journal-title":"Drug Metab Pharmacokinet"},{"key":"426_CR42","volume-title":"ADME-enabling technologies in drug design and development","author":"N Penner","year":"2012","unstructured":"Penner N, Woodward C, Prakash C (2012) Drug metabolizing enzymes and biotransformation reactions. In: Zhang D, Austin SS (eds) ADME-enabling technologies in drug design and development. Wiley, New York"},{"issue":"4","key":"426_CR43","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1124\/dmd.113.056374","volume":"42","author":"JT Barr","year":"2014","unstructured":"Barr JT, Choughule KV, Nepal S, Wong T, Chaudhry AS, Joswig-Jones CA, Zientek M, Strom SC, Schuetz EG, Thummel KE et al (2014) Why do most human liver cytosol preparations lack xanthine oxidase activity? Drug Metab Dispos 42(4):695\u2013699","journal-title":"Drug Metab Dispos"},{"issue":"16","key":"426_CR44","doi-asserted-by":"publisher","first-page":"5906","DOI":"10.1016\/j.bmc.2009.07.002","volume":"17","author":"P Gleeson","year":"2009","unstructured":"Gleeson P, Bravi G, Modi S, Lowe D (2009) ADMET rules of thumb II: a comparison of the effects of common substituents on a range of ADMET parameters. Bioorg Med Chem 17(16):5906\u20135919","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"426_CR45","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1021\/ci100258p","volume":"50","author":"G Papadatos","year":"2010","unstructured":"Papadatos G, Alkarouri M, Gillet VJ, Willett P, Kadirkamanathan V, Luscombe CN, Bravi G, Richmond NJ, Pickett SD, Hussain J et al (2010) Lead optimization using matched molecular pairs: inclusion of contextual information for enhanced prediction of HERG inhibition, solubility, and lipophilicity. J Chem Inf Model 50(10):1872\u20131886","journal-title":"J Chem Inf Model"},{"issue":"1","key":"426_CR46","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1021\/acs.jcim.8b00520","volume":"59","author":"A Koutsoukas","year":"2019","unstructured":"Koutsoukas A, Chang G, Keefer CE (2019) In-silico extraction of design ideas using MMPA-by-QSAR and its application on ADME endpoints. J Chem Inf Model 59(1):477\u2013485","journal-title":"J Chem Inf Model"},{"issue":"Pt 3","key":"426_CR47","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1042\/bst0310611","volume":"31","author":"S Ekins","year":"2003","unstructured":"Ekins S (2003) In silico approaches to predicting drug metabolism, toxicology and beyond. Biochem Soc Trans 31(Pt 3):611\u2013614","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"426_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10822-009-9309-9","volume":"24","author":"Y Hu","year":"2010","unstructured":"Hu Y, Unwalla R, Denny RA, Bikker J, Di L, Humblet C (2010) Development of QSAR models for microsomal stability: identification of good and bad structural features for rat, human and mouse microsomal stability. J Comput Aided Mol Des 24(1):23\u201335","journal-title":"J Comput Aided Mol Des"},{"issue":"12","key":"426_CR49","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10822-007-9124-0","volume":"21","author":"PH Lee","year":"2007","unstructured":"Lee PH, Cucurull-Sanchez L, Lu J, Du YJ (2007) Development of in silico models for human liver microsomal stability. J Comput Aided Mol Des 21(12):665\u2013673","journal-title":"J Comput Aided Mol Des"},{"issue":"6","key":"426_CR50","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jmgm.2007.06.005","volume":"26","author":"Y Sakiyama","year":"2008","unstructured":"Sakiyama Y, Yuki H, Moriya T, Hattori K, Suzuki M, Shimada K, Honma T (2008) Predicting human liver microsomal stability with machine learning techniques. J Mol Graph Model 26(6):907\u2013915","journal-title":"J Mol Graph Model"},{"issue":"19","key":"426_CR51","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1021\/jm0703690","volume":"50","author":"RA Torres","year":"2007","unstructured":"Torres RA, Korzekwa KR, McMasters DR, Fandozzi CM, Jones JP (2007) Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase. J Med Chem 50(19):4642\u20134647","journal-title":"J Med Chem"},{"issue":"7","key":"426_CR52","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1021\/acs.jmedchem.7b00019","volume":"60","author":"Y Xu","year":"2017","unstructured":"Xu Y, Li L, Wang Y, Xing J, Zhou L, Zhong D, Luo X, Jiang H, Chen K, Zheng M et al (2017) Aldehyde oxidase mediated metabolism in drug-like molecules: a combined computational and experimental study. J Med Chem 60(7):2973\u20132982","journal-title":"J Med Chem"},{"issue":"4","key":"426_CR53","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1021\/mp300568r","volume":"10","author":"JP Jones","year":"2013","unstructured":"Jones JP, Korzekwa KR (2013) Predicting intrinsic clearance for drugs and drug candidates metabolized by aldehyde oxidase. Mol Pharm 10(4):1262\u20131268","journal-title":"Mol Pharm"},{"issue":"8","key":"426_CR54","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1124\/dmd.112.045823","volume":"40","author":"D Dalvie","year":"2012","unstructured":"Dalvie D, Sun H, Xiang C, Hu Q, Jiang Y, Kang P (2012) Effect of structural variation on aldehyde oxidase-catalyzed oxidation of zoniporide. Drug Metab Dispos 40(8):1575\u20131587","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"426_CR55","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1016\/j.bmcl.2012.02.069","volume":"22","author":"DC Pryde","year":"2012","unstructured":"Pryde DC, Tran TD, Jones P, Duckworth J, Howard M, Gardner I, Hyland R, Webster R, Wenham T, Bagal S et al (2012) Medicinal chemistry approaches to avoid aldehyde oxidase metabolism. Bioorg Med Chem Lett 22(8):2856\u20132860","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"426_CR56","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/minf.201200020","volume":"31","author":"DJ Warner","year":"2012","unstructured":"Warner DJ, Bridgland-Taylor MH, Sefton CE, Wood DJ (2012) Prospective prediction of antitarget activity by matched molecular pairs analysis. Mol Inform 31(5):365\u2013368","journal-title":"Mol Inform"},{"issue":"4","key":"426_CR57","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1021\/ci500012n","volume":"54","author":"JM Beck","year":"2014","unstructured":"Beck JM, Springer C (2014) Quantitative structure\u2013activity relationship models of chemical transformations from matched pairs analyses. J Chem Inf Model 54(4):1226\u20131234","journal-title":"J Chem Inf Model"},{"issue":"3","key":"426_CR58","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/00031305.1992.10475879","volume":"46","author":"NS Altman","year":"1992","unstructured":"Altman NS (1992) An Introduction to kernel and nearest-neighbor nonparametric regression. Am Stat 46(3):175\u2013185","journal-title":"Am Stat"},{"issue":"8","key":"426_CR59","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1109\/34.709601","volume":"20","author":"TK Ho","year":"1998","unstructured":"Ho TK (1998) The random subspace method for constructing decision forests. IEEE T Pattern Anal 20(8):832\u2013844","journal-title":"IEEE T Pattern Anal"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-020-00426-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13321-020-00426-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-020-00426-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T15:57:39Z","timestamp":1722700659000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-020-00426-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["426"],"URL":"https:\/\/doi.org\/10.1186\/s13321-020-00426-7","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]},"assertion":[{"value":"30 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}